Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.19 is 99% below its 5-year average of 14.11, near the low end of its 5-year range (0.19–20.52).
98.71% below its 12-month average of 14.72.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 1.19.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-26T00:15:56.818Z. Historical observations retain their original dates. Historical series through 2026-09-11.
EARNINGS PER SHARE (EPS)
0.19
EARNINGS PER SHARE (EPS) AVG TTM
14.72
EARNINGS PER SHARE (EPS) AVG 3Y
15.46
EARNINGS PER SHARE (EPS) AVG 5Y
14.11
EARNINGS PER SHARE (EPS) AVG 10Y
9.24
EARNINGS PER SHARE (EPS) AVG 15Y
6.63
EARNINGS PER SHARE (EPS) AVG 20Y
5.31
CURRENT VS TTM AVG
-98.71%
CURRENT VS 3Y AVG
-98.77%
CURRENT VS 5Y AVG
-98.65%
CURRENT VS 10Y AVG
-97.94%
CURRENT VS 15Y AVG
-97.14%
CURRENT VS 20Y AVG
-96.42%
Molina Healthcare, Inc.
Market Cap
$9.96B
Earnings Per Share (EPS)
0.19
TTM Avg
14.72
3Y Avg
15.46
5Y Avg
14.11
Market Cap
$10.05B
Earnings Per Share (EPS)
3.89
TTM Avg
2.37
3Y Avg
1.93
5Y Avg
1.71
Market Cap
$9.84B
Earnings Per Share (EPS)
3.43
TTM Avg
3.18
3Y Avg
3.37
5Y Avg
3.47
Market Cap
$10.21B
Earnings Per Share (EPS)
6.38
TTM Avg
5.63
3Y Avg
4.78
5Y Avg
4.31
Market Cap
$10.26B
Earnings Per Share (EPS)
8.25
TTM Avg
-18.74
3Y Avg
-45.28
5Y Avg
14.90
Market Cap
$10.51B
Earnings Per Share (EPS)
5.76
TTM Avg
5.64
3Y Avg
5.43
5Y Avg
9.01
Market Cap
$10.80B
Earnings Per Share (EPS)
2.93
TTM Avg
1.92
3Y Avg
1.82
5Y Avg
4.51
Market Cap
$10.83B
Earnings Per Share (EPS)
24.38
TTM Avg
20.29
3Y Avg
15.04
5Y Avg
13.87
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Molina Healthcare, Inc. (MOH) | $9.96B | 0.19 | 14.72 | 15.46 | 14.11 |
| Globus Medical, Inc. (GMED)vs › | $10.05B | 3.89 | 2.37 | 1.93 | 1.71 |
| Henry Schein, Inc. (HSIC)vs › | $9.84B | 3.43 | 3.18 | 3.37 | 3.47 |
| The Ensign Group, Inc. (ENSG)vs › | $10.21B | 6.38 | 5.63 | 4.78 | 4.31 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.26B | 8.25 | -18.74 | -45.28 | 14.90 |
| Insulet Corp. (PODD)vs › | $9.43B | 5.35 | 4.74 | 3.13 | 2.14 |
| Align Technology, Inc. (ALGN)vs › | $10.51B | 5.76 | 5.64 | 5.43 | 9.01 |
| The Cooper Companies, Inc. (COO)vs › | $10.80B | 2.93 | 1.92 | 1.82 | 4.51 |
| Universal Health Services, Inc. (UHS)vs › | $10.83B | 24.38 | 20.29 | 15.04 | 13.87 |
| Bio-Techne Corporation (TECH)vs › | $11.37B | 1.16 | 0.82 | 1.13 | 1.19 |
Trailing EPS (TTM)
$0.19
Forward EPS (Est.)
$5.23
P/E Ratio
1004.2
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 8.93 |
| 2024-12-31 | 20.52 |
| 2023-12-31 | 18.71 |
| 2022-12-31 | 13.70 |
| 2021-12-31 | 11.40 |
| 2020-12-31 | 11.41 |
| 2019-12-31 | 11.85 |
| 2018-12-31 | 10.61 |
| 2017-12-31 | -9.14 |
| 2016-12-31 | 0.93 |
| 2015-12-31 | 2.75 |
| 2014-12-31 | 1.33 |
| 2013-12-31 | 1.16 |
| 2012-12-31 | 0.21 |
| 2011-12-31 | 0.45 |
| 2010-12-31 | 1.34 |
| 2009-12-31 | 0.79 |
| 2008-12-31 | 1.50 |
| 2007-12-31 | 1.37 |
| 2006-12-31 | 1.09 |
| 2005-12-31 | 0.67 |
| 2004-12-31 | 1.38 |
| 2003-12-31 | 1.27 |
| 2002-12-31 | 1.02 |
| 2001-12-31 | 1.01 |
| 2000-12-31 | 0.50 |
| 1999-12-31 | 0.31 |
